IT1254210B - Composizioni dietetiche e/o farmaceutiche a base di batteri lattici liofilizzati, loro preparazione e impiego - Google Patents

Composizioni dietetiche e/o farmaceutiche a base di batteri lattici liofilizzati, loro preparazione e impiego

Info

Publication number
IT1254210B
IT1254210B ITMI920256A ITMI920256A IT1254210B IT 1254210 B IT1254210 B IT 1254210B IT MI920256 A ITMI920256 A IT MI920256A IT MI920256 A ITMI920256 A IT MI920256A IT 1254210 B IT1254210 B IT 1254210B
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
compositions based
lactic bacteria
dietary
lyophilized lactic
Prior art date
Application number
ITMI920256A
Other languages
English (en)
Inventor
Simone Claudio De
Original Assignee
Simone Claudio De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Simone Claudio De filed Critical Simone Claudio De
Publication of ITMI920256A0 publication Critical patent/ITMI920256A0/it
Priority to ITMI920256A priority Critical patent/IT1254210B/it
Priority to ES92830653T priority patent/ES2120440T3/es
Priority to EP92830653A priority patent/EP0555618B1/en
Priority to DE69226622T priority patent/DE69226622T2/de
Priority to DK92830653T priority patent/DK0555618T3/da
Priority to JP4334600A priority patent/JPH0656680A/ja
Publication of ITMI920256A1 publication Critical patent/ITMI920256A1/it
Priority to US08/448,787 priority patent/US5716615A/en
Application granted granted Critical
Publication of IT1254210B publication Critical patent/IT1254210B/it
Priority to US11/375,704 priority patent/USRE40023E1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/169—Plantarum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/21—Streptococcus, lactococcus
    • A23V2400/249—Thermophilus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum

Abstract

Composizioni farmaceutiche a base di batteri lattici liofilizzati altamente concentrati, contenenti anche eccipienti farmacologicamente accettabili ed eventualmente farmaci adatti fisiologicamente compatibili, sono indicate nel ripristino della massa della mucosa intestinale, nella modulazione della cinetica cellulare epiteliale e del potenziale enzimatico dell'intestino alterati a seguito di condizioni stressanti, inoltre nel caso di gastroenteriti, coliti, costipazione, diarrea, per la ricolonizzazione dell'intestino dopo squilibri alimentari, interventi chirurgici, chemioterapia e malattie infettive, epatopatie conseguenti a cause tossiche, metaboliche o infettive, come coadiuvanti nel controllo dell'iperammoniemia e della endotossinemia in corso di insufficienza epatica, in disregolazioni dell'immunità umorale e cellulo-mediata mucosale e sistemica associati ad immunodeficienze secondarie e per dislipidemie ed ipercolesterolemia e come coadiuvante nella terapia diabetica.
ITMI920256A 1992-02-10 1992-02-10 Composizioni dietetiche e/o farmaceutiche a base di batteri lattici liofilizzati, loro preparazione e impiego IT1254210B (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
ITMI920256A IT1254210B (it) 1992-02-10 1992-02-10 Composizioni dietetiche e/o farmaceutiche a base di batteri lattici liofilizzati, loro preparazione e impiego
DK92830653T DK0555618T3 (da) 1992-02-10 1992-12-04 Et diætetisk og/eller farmaceutisk præparat indeholdende lyophiliserede mælkesyrebakterier, samt dets fremstilling og brug
EP92830653A EP0555618B1 (en) 1992-02-10 1992-12-04 Dietetic and/or pharmaceutical compositions containing lyophilized lactic bacteria
DE69226622T DE69226622T2 (de) 1992-02-10 1992-12-04 Lyophilisierte Bakterien enthaltende Diät- oder Arzneimittelnzusammenstellungen
ES92830653T ES2120440T3 (es) 1992-02-10 1992-12-04 Composiciones dieteticas o farmaceuticas que comprenden bacterias lacticas liofilizadas.
JP4334600A JPH0656680A (ja) 1992-02-10 1992-12-15 凍結乾燥された乳酸菌を含有する栄養学的及び／又は薬学的組成物、それらの調製及び使用
US08/448,787 US5716615A (en) 1992-02-10 1995-05-24 Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
US11/375,704 USRE40023E1 (en) 1992-02-10 2006-03-15 Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI920256A IT1254210B (it) 1992-02-10 1992-02-10 Composizioni dietetiche e/o farmaceutiche a base di batteri lattici liofilizzati, loro preparazione e impiego

Publications (3)

Publication Number Publication Date
ITMI920256A0 ITMI920256A0 (it) 1992-02-10
ITMI920256A1 ITMI920256A1 (it) 1993-08-10
IT1254210B true IT1254210B (it) 1995-09-14

Family

ID=11361865

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI920256A IT1254210B (it) 1992-02-10 1992-02-10 Composizioni dietetiche e/o farmaceutiche a base di batteri lattici liofilizzati, loro preparazione e impiego

Country Status (6)

Country Link
EP (1) EP0555618B1 (it)
JP (1) JPH0656680A (it)
DE (1) DE69226622T2 (it)
DK (1) DK0555618T3 (it)
ES (1) ES2120440T3 (it)
IT (1) IT1254210B (it)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9318439D0 (en) * 1993-09-06 1993-10-20 Zeneca Ltd Probiotics
AT405235B (de) * 1995-11-02 1999-06-25 Helmut Dr Viernstein Probiotisch wirksame formulierung
US5902578A (en) * 1996-03-25 1999-05-11 Abbott Laboratories Method and formula for the prevention of diarrhea
AUPN907296A0 (en) * 1996-04-02 1996-04-26 Commonwealth Scientific And Industrial Research Organisation Biocontrol agents for use in treatment of opportunistic infections
IT1288119B1 (it) * 1996-06-28 1998-09-10 Renata Maria Anna Ve Cavaliere Composizioni dietetiche da utilizzare nell'alimentazione per via enterica
DE19637112C2 (de) * 1996-09-12 1999-11-18 Matthias Kleespies Verfahren zur Herstellung fester Körper und Verwendung derartiger Körper
DE69600525T2 (de) * 1996-12-23 1998-12-10 Sitia Yomo Spa Lyophilisierte, lebende Bakerien enthaltende Nahrungszusammensetzung
RO112995B1 (ro) * 1997-08-05 1998-03-30 Rodica Teodorescu Produs medicamentos pentru terapia colonului
CN1119154C (zh) * 1998-01-20 2003-08-27 上海信谊药业有限公司 双歧三联活菌制剂及制备方法
EP1020123A1 (en) * 1999-01-18 2000-07-19 Sitia-Yomo S.p.A. Beverages containing live lactic bacteria
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
CN1446103A (zh) * 2000-07-03 2003-10-01 普罗本多有限公司 采用益生菌治疗内毒素血症及相关疾病
IL157071A0 (en) * 2001-02-06 2004-02-08 Nestle Sa Endotoxine binding by lactic acid bacteria and bifidobacteria
WO2003018051A1 (en) * 2001-08-27 2003-03-06 Vic Jira Anti-fungal composition
SE526711C2 (sv) * 2003-01-31 2005-10-25 Probi Ab Nya stammar av Bifidobacterium med förmåga att överleva i magtarmkanalen och producera glutamin in vivo, samt kompositioner och användningar därav
JP2004262773A (ja) * 2003-02-17 2004-09-24 Ryoshoku Kenkyukai 免疫機能改善を目的としたビフィズス菌製剤
ITRM20040505A1 (it) * 2004-10-15 2005-01-15 Cd Invest Liofilizzati di batteri lattici e bifidobatteri ad alta dispersibilita'.
JP5413819B2 (ja) * 2008-02-08 2014-02-12 国立大学法人広島大学 肝機能改善剤およびその製造用ツール、ならびにこれらの利用
FR2930443B1 (fr) * 2008-04-29 2010-06-25 Oreal Produit extemporane de soin a base d'un lyophilisat de microorganisme et de tensioactif(s) de hlb superieur ou egal a 12
JP2009102324A (ja) * 2008-11-27 2009-05-14 Morishita Jintan Kk 乳酸菌含有血中アンモニア低減剤
ITMO20090067A1 (it) * 2009-03-23 2010-09-24 Ct Sperimentale Del Latte S P A Composizione a base di microrganismi utilizzabile per preparare un prodotto alimentare
WO2011098568A1 (en) 2010-02-11 2011-08-18 Technische Universität München Lactocepins for use in the treatment of ip-10-mediated inflammatory diseases
JP6020981B2 (ja) * 2010-10-15 2016-11-02 国立研究開発法人農業・食品産業技術総合研究機構 カテコールアミン認識性を指標に選抜した微生物とカテコールアミン含有組成物
KR20200106088A (ko) 2012-01-16 2020-09-10 엘라자베스 맥켄나 간 질환들 및 장애들의 치료를 위한 조성물들 및 방법들
WO2014047588A1 (en) 2012-09-21 2014-03-27 Elizabeth Mckenna Naturally occurring cpg oligonucleotide compositions and therapeutic applications thereof
JP6051353B2 (ja) * 2015-03-09 2016-12-27 株式会社東洋新薬 血中コレステロール上昇抑制剤
JP2019514409A (ja) 2016-05-11 2019-06-06 セーホーエル．ハンセン アクティーゼルスカブ 常温保存用の熱処理食料製品のための乳酸菌
KR102009731B1 (ko) 2019-04-15 2019-08-12 주식회사 쎌바이오텍 단백질 가수분해물을 이용한 단백질-다당류 이중코팅 유산균의 제조방법
BR112022004492A2 (pt) 2019-09-12 2022-05-31 Chr Hansen As Bactérias de ácido lático para um produto alimentar tratado termicamente para armazenamento à temperatura ambiente

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60149527A (ja) * 1984-01-17 1985-08-07 Seikenkai 生体内脱臭剤
JPH0696538B2 (ja) * 1985-12-19 1994-11-30 株式会社アドバンス 抗発癌剤
US5143845A (en) * 1986-09-03 1992-09-01 Toa Pharmaceutical Co., Ltd. Mixture of saccarifying lactic acid producing and butyric acid producing bacteria
JPH0774158B2 (ja) * 1986-09-03 1995-08-09 東亜薬品工業株式会社 ３種菌共生混合物
JPS6391076A (ja) * 1986-10-06 1988-04-21 Toa Yakuhin Kogyo Kk ３種菌の培養法
EP0291578A1 (en) * 1987-05-20 1988-11-23 Kopalnia Soli "Wieliczka" Table salt enriched in bioelements
JP2612001B2 (ja) * 1987-09-04 1997-05-21 フロイント産業株式会社 腸内有用細菌含有顆粒およびその製造方法
US4806368A (en) * 1987-09-16 1989-02-21 Reddy Malireddy S Shelf life and subsequent growth of lactobacillus acidophilus, propionibacterium shermanii and leuconostoc citrovorum in dietary fiber based supplement preparation

Also Published As

Publication number Publication date
JPH0656680A (ja) 1994-03-01
DE69226622D1 (de) 1998-09-17
ITMI920256A1 (it) 1993-08-10
EP0555618A3 (en) 1994-06-22
EP0555618A2 (en) 1993-08-18
ITMI920256A0 (it) 1992-02-10
ES2120440T3 (es) 1998-11-01
DE69226622T2 (de) 1999-02-11
EP0555618B1 (en) 1998-08-12
DK0555618T3 (da) 1999-05-17

Similar Documents

Publication Publication Date Title
IT1254210B (it) Composizioni dietetiche e/o farmaceutiche a base di batteri lattici liofilizzati, loro preparazione e impiego
Nakanishi et al. Positively charged liposome functions as an efficient immunoadjuvant in inducing cell-mediated immune response to soluble proteins
Dannenberg Jr Immunopathogenesis of pulmonary tuberculosis
HK1050839A1 (en) Use of pharmaceutical compositions comprising oxcarbazepine in the fasted state
PL335370A1 (en) Orally administered preparation for preventing and treating bacterial infections caused by helicobacter sp.
CA2157879A1 (en) Methods for Inhibiting Bone Loss with 3,4-Diarylchroman
EG19642A (en) A process for the preparation of oral composition for the treatment of inflammatory bowel diseases
AU4422197A (en) Delivery of therapeutic gene products by intestinal cell expression
IT1245761B (it) Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.
HUP0104249A2 (hu) Szív és érrendszeri betegségekkel összefüggő megbetegedési és halálozási arányok csökkentésére szolgáló gyógyszerkészítmény angiotenzin átalakító enzim inhibitor és aldoszteron antagonista együttes alkalmazásával
HUP9901707A2 (hu) Gasztrointesztinális rendellenességek megelőzésére és kezelésére szolgáló gyógyászati, és diétás készítmények
CY1106137T1 (el) Φαρμακευτικη συνθεση πepιλαμβανουσα λουμιρακοξιμπη
EE04606B1 (et) H+, K+-ATPaasi inhibiitori kasutamine ravimi valmistamiseks peroraalseks manustamiseks
RU2008107935A (ru) Применение специфических молочнокислых бактерий для получения иммуномодулирующих композиций
MY111871A (en) Heterocyclic compounds.
SE9704693D0 (sv) Method of the prophylactic treatment of mastitis
NO962752L (no) Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
AU1227700A (en) Method for the production of purified invasin protein and use thereof
MD2355F1 (en) Method of preimplanting preparation
MORIMOTO et al. A case of cefmenoxime-induced granulocytopenia in patient with chronic osteomyelitis of mandibule
MD1247G2 (ro) Metodă de obturare a fistulelor labiale intestinale externe
ES8303915A1 (es) "procedimiento para la preparacion de comprimidos a base del antibiotico fosfomicina".
RU97116776A (ru) Способ профилактики тромбоэмболических осложнений у хирургических больных
Shimosaka The Importance of Immunotherapy in Cancer Treatment